Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Delivery Systems for Leishmania Vaccine Development Publisher Pubmed



Gholami E1, 2 ; Zahedifard F1 ; Rafati S1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran
  2. 2. School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Expert Review of Vaccines Published:2016


Abstract

ABSTRACT: Leishmaniasis is a neglected disease and is endemic in tropical and sub-tropical areas worldwide. Lifelong immunity after recovery indicates that vaccination could be a promising approach to overcome the disease. Although different antigens have been successfully tested against all clinical forms, none of them have been shown to fulfill the safety and efficiency requirements for human applications. Hence, strong vehicles are needed to carry antigens of interest and potentiate its presence in the body. So far, various live or chemical carriers have been applied to reinforce the immunological effects of ideal antigens. In the current review, the recent attempts in this field have been summarized. © 2016 Informa UK Limited, trading as Taylor & Francis Group.
Related Docs
View other Related Docs
1. Development of Nano-Carriers for Leishmania Vaccine Delivery, Expert Opinion on Drug Delivery (2020)
2. The Role of Mpl and Imiquimod Adjuvants in Enhancement of Immune Response and Protection in Balb/C Mice Immunized With Soluble Leishmania Antigen (Sla) Encapsulated in Nanoliposome, Artificial Cells# Nanomedicine and Biotechnology (2018)
3. The Role of Lpd-Nanoparticles Containing Recombinant Major Surface Glycoprotein of Leishmania (Rgp63) in Protection Against Leishmaniasis in Murine Model, Immunopharmacology and Immunotoxicology (2018)
4. The Role of Iscomatrix Bilayer Composition to Induce a Cell Mediated Immunity and Protection Against Leishmaniasis in Balb/C Mice, Iranian Journal of Basic Medical Sciences (2016)
5. Leishmania Major P27 Gene Knockout As a Novel Live Attenuated Vaccine Candidate: Protective Immunity and Efficacy Evaluation Against Cutaneous and Visceral Leishmaniasis in Balb/C Mice, Vaccine (2019)
6. A Phospholipase-A Activity in Soluble Leishmania Antigens Causes Instability of Liposomes, Current Drug Delivery (2020)
7. Evaluation of Immune Response Against Leishmaniasis in Balb/C Mice Immunized With Cationic Dotap/Dope/Chol Liposomes Containing Soluble Leishmania Major Antigens, Iranian Journal of Parasitology (2019)
8. Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (Alm) and Quillaja Saponins, Iranian Journal of Pharmaceutical Research (2016)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (5)
Alireza Vatanara (3)
Other Related Docs
9. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation, Iranian Journal of Immunology (2015)
10. A Non-Pathogenic Leishmania Tarentolae Vector Based- Hcv Polytope Dna Vaccine Elicits Potent and Long Lasting Th1 and Ctl Responses in Balb/C Mice Model, Molecular Immunology (2019)
11. Coadminstration of L. Major Amastigote Class I Nuclease (Rlmacin) With Lpd Nanoparticles Delays the Progression of Skin Lesion and the L. Major Dissemination to the Spleen in Balb/C Mice-Based Experimental Setting, Acta Tropica (2016)
12. Sphingomyelin Liposome Bearing Whole Leishmania Lysate Antigens Induce Strong Th2 Immune Response in Balb/C Mice, Iranian Journal of Basic Medical Sciences (2021)
13. Development of a New Live Attenuated Leishmania Major P27 Gene Knockout: Safety and Immunogenicity Evaluation in Balb/C Mice, Cellular Immunology (2018)
14. Leishmania Tarentolae Secreting the Sand Fly Salivary Antigen Ppsp15 Confers Protection Against Leishmania Major Infection in a Susceptible Balb/C Mice Model, Molecular Immunology (2015)
15. Pegylation of Cationic Liposomes Encapsulating Soluble Leishmania Antigens Reduces the Adjuvant Efficacy of Liposomes in Murine Model, Parasite Immunology (2017)
16. Cationic Liposomes Formulated With a Novel Whole Leishmania Lysate (Wll) As a Vaccine for Leishmaniasis in Murine Model, Immunobiology (2018)
17. Live Attenuated Leishmania Major P27 Gene Knockout As a Novel Vaccine Candidate: A Study on Safety, Protective Immunity and Efficacy Against Canine Leishmaniasis Caused by Leishmania Infantum, Acta Tropica (2022)
18. Live Attenuated Leishmania Infantum Centrin Deleted Mutant (Licen-/-) As a Novel Vaccine Candidate: A Field Study on Safety, Immunogenicity, and Efficacy Against Canine Leishmaniasis, Comparative Immunology# Microbiology and Infectious Diseases (2023)
19. A State-Of-The-Art Review on Solid Lipid Nanoparticles As a Nanovaccines Delivery System, Journal of Drug Delivery Science and Technology (2023)
20. Dna Plasmid Coding for Phlebotomus Sergenti Salivary Protein Pssp9, a Member of the Sp15 Family of Proteins, Protects Against Leishmania Tropica, PLoS Neglected Tropical Diseases (2019)
21. Polymeric Nanoparticles for Dna Vaccine-Based Cancer Immunotherapy: A Review, Biotechnology Letters (2023)
22. Combinatorial Delivery of Antigen and Tlr Agonists Via Plga Nanoparticles Modulates Leishmania Major-Infected-Macrophages Activation, Biomedicine and Pharmacotherapy (2021)
23. Multi-Antigen Vaccination With Lpd Nanoparticles Containing Rgp63 and Rlmac1n Proteins Induced Effective Immune Response Against Leishmaniasis in Animal Model, Journal of Drug Delivery Science and Technology (2021)
24. Preparation of Nanoliposomes Containing Her2/Neu (P5+435) Peptide and Evaluation of Their Immune Responses and Anti-Tumoral Effects As a Prophylactic Vaccine Against Breast Cancer, PLoS ONE (2020)
25. Preparation, Statistical Optimization and in Vitro Characterization of Solid Lipid Nanoparticles As a Potential Vehicle for Transdermal Delivery of Tramadol Hydrochloride As a Hydrophilic Compound, Nanomedicine Research Journal (2020)
26. Lipid-Based Nanoparticles for Drug Delivery Systems, Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (2018)
27. P435 Her2/Neu-Derived Peptide Conjugated to Liposomes Containing Dope As an Effective Prophylactic Vaccine Formulation for Breast Cancer, Artificial Cells# Nanomedicine and Biotechnology (2019)
28. Nanomedicine and Advanced Technologies for Burns: Preventing Infection and Facilitating Wound Healing, Advanced Drug Delivery Reviews (2018)
29. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol, Frontiers in Bioengineering and Biotechnology (2021)
30. Engineering and Design of Promising T-Cell-Based Multi-Epitope Vaccine Candidates Against Leishmaniasis, Scientific Reports (2023)
31. Toxicity Concerns of Nanocarriers, Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes (2017)
32. Preparation of Transgenic Iranian Lizard Leishmania Coding Hil-12, Iranian Journal of Microbiology (2017)
33. Effects of Combined Therapy With Silymarin and Glucantime on Leishmaniasis Induced by Leishmania Major in Balb/C Mice, Drug Research (2015)
34. Evolution of Antigen-Specific Immune Responses in Cutaneous Leishmaniasis Patients, Parasite Immunology (2021)
35. The Synthesis, Application and Therapeutic Perspectives of Medicinal Plants-Based Solid Lipid Nanoparticles: A Comprehensive Review, Advances in Traditional Medicine (2025)
36. Nanoimmunoengineering Strategies in Cancer Diagnosis and Therapy, Clinical and Translational Oncology (2023)
37. In-Vitro and In-Vivo Comparison of Rsag1-Loaded Plga Prepared by Encapsulation and Adsorption Methods As an Efficient Vaccine Against Toxoplasma Gondii”, Journal of Drug Delivery Science and Technology (2020)
38. A Nano-Liposome Vaccine Carrying E75, a Her-2/Neu-Derived Peptide, Exhibits Significant Antitumour Activity in Mice, Journal of Drug Targeting (2018)
39. Nanoliposomes Carrying Her2/Neu-Derived Peptide Ae36 With Cpg-Odn Exhibit Therapeutic and Prophylactic Activities in a Mice Tubo Model of Breast Cancer, Immunology Letters (2017)
40. Synergistic Effect of Rsag1 and Rgra2 Antigens Formulated in Plga Microspheres in Eliciting Immune Protection Against Toxoplasama Gondii, Experimental Parasitology (2016)
41. Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds, Frontiers in Chemistry (2022)
42. Recognition of Immunoreactive Proteins in Leishmania Infantum Amastigote-Like and Promastigote Using Sera of Visceral Leishmaniasis Patients: A Preliminary Study, Acta Parasitologica (2024)
43. Targeting Neuroinflammation by Intranasal Delivery of Nanoparticles in Neurological Diseases: A Comprehensive Review, Naunyn-Schmiedeberg's Archives of Pharmacology (2022)